MGP invests in seed and early stage companies. Within Life Sciences, the fund focuses on Medical Devices, Diagnostics, and Opportunistic Drug Development. Our firm places a premium on those innovations that have existing intellectual property or a novel scientific foundation for building intellectual property. AgTech investments focus on disruptive technologies that have a meaningful impact on global animal health and agriculture. Technology investments focus on Business and Healthcare Technology, targeting those ideas with quantifiable development risk and a rapid path to market.